UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Understand the reasons for choosing a retirement plan over a 401k. Make informed decisions for a secure retirement.
23,531 articlesAs UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
When a company director sells millions after a sharp rally, it stirs worry. But insider activity is nuanced. This gui...
A once-tiny energy startup sparked a rally after finally showing a profitable revenue stream through an acquired subs...
Old Dominion Freight Line (ODFL) faced an 11.9% drop after a Citi downgrade, despite strong fundamentals. This articl...
Nvidia’s 2026 story isn’t all hype. This guide explains why the stock is under pressure, the role of the Magnificent ...
O-I Glass has climbed about 17% over the past year, even as a large fund unloaded roughly $80 million worth of stock....
Circle Internet Group stock took a sharp drop as headlines pointed to potential US regulation that could curb stablec...
Investors are watching GameSquare closely as 2025 earnings unfold. This guide explains what to look for in the Q4 res...
Want to know if Bristol Myers Squibb is worth a spot in your portfolio? This deep dive highlights three core reasons ...
A recent CFO Form 4 shows a small share disposition at Synaptics while the company reports 10% revenue growth. This a...
When a high-profile buyout falls short of expectations, stocks swing and traders scramble for context. This deep dive...
In 2026, savvy investors favor dividend stocks that reliably pay and grow. This article highlights two no-brainer div...